Blog | Association for Accessible Medicines

AAM Statement - President Trump’s Blueprint to Lower Drug Prices

Jun 20, 2018 | Craig Burton

Why Seniors Are Paying More as Drug Prices Fall

Jun 6, 2018 | Jeff Watson

Pass the CREATES Act to End Manipulative Practices That Cost Our Patients Billions

America's Opioid Epidemic: Youth Awareness & Prevention at Washington, DC's Newseum May 23, 2018 - Chip Davis

May 29, 2018 | Rachel Schwartz

AAM Speaks on Involvement in the Prescription Drug Safety Network

May 22, 2018 | Erica Klinger

Gold and Platinum Hermes Awards for AAM

May 14, 2018 | Jennifer Soup

Reinventing AAM’s Meetings

May 10, 2018 | David Gaugh

FDA Approvals: Good News for Patients, More Work to Do (Part 2)

Dear Mr. President—On the Eve of Your Drug Pricing Speech

May 10, 2018 | Chip Davis

Dear Mr. President—On the Eve of Your Drug-Pricing Speech

May 9, 2018 | David Gaugh

FDA Approvals: Good News for Patients, More Work to Do (Part 1)

May 3, 2018 | Christine Simmon

The Biosimilars Council Congressional Briefing: Five Takeaways

Apr 25, 2018 | Rachel Schwartz

Together! Engaging Women in Health Policy

Apr 13, 2018 | Erik Komendant

Cotton-McCaskill PACED Act Would Help Patients Gain Access to More Affordable Generics

AAM Applauds House Passage of FDA User Fee Reauthorization

Apr 9, 2018 | Jeff Francer

AAM Has Adopted a Code of Business Ethics. Here’s What That Means.